v3.26.1
SCHEDULE OF OPTION ACTIVITY FOR NEURONOS (Details) - 2023 Neuro Nos Ltd Equity Incentive Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding at beginning of period 1,224,139
Weighted Average Exercise Price - Options, Outstanding at beginning of period $ 0.14
Aggregate Intrinsic Value, Outstanding at beginning of period $ 3,501
Number of Options, Granted 169,913 1,224,139
Weighted Average Exercise Price of Options, Granted $ 3.00 $ 0.14
Number of Options, Exercised
Weighted Average Exercise Price of Options, Exercised
Number of Options, Forfeited (134,723)
Weighted average exercise price - options, forfeited $ 2.82
Weighted Average Remaining Contractual Life of Options, Outstanding 8 years 1 month 6 days 9 years 1 month 6 days
Number of Options, Outstanding at ending of period 1,259,329 1,224,139
Weighted Average Exercise Price - Options, Outstanding at ending of period $ 0.24 $ 0.14
Aggregate Intrinsic Value, Outstanding at end of period $ 3,477 $ 3,501
Number of Options Outstanding, Exercisable 622,341  
Weighted Average Exercise Price - Options, Exercisable $ 0.19  
Weighted Average Remaining Contractual Life of Options, Exercisable 8 years 1 month 6 days  
Aggregate Intrinsic Value, Exercisable $ 1,748